CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Recruiting

Phase 1

Phase 2

CNP-103CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Sponsor:

COUR Pharmaceutical Development Company, Inc.

Code:

NCT06783309

Conditions

Type 1 Diabetes Mellitus

T1D

T1DM

T1DM - Type 1 Diabetes Mellitus

Type 1 Diabetes in Adolescence

Eligibility Criteria

Sex: All

Age: 12 - 35

Healthy Volunteers: Not accepted

Interventions

CNP-103

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-20. This information was provided to ClinicalTrials.gov by COUR Pharmaceutical Development Company, Inc. on 2025-09-18.